Larimar Therapeutics Welcomes Dr. Gopi Shankar as Chief Development Officer
Larimar Therapeutics Appoints Dr. Gopi Shankar as Chief Development Officer Biologics expert and long-time veteran of Johnson & Johnson will be responsible for the strategic development of Larimar’s clinical and R&D programs BALA CYNWYD, Pa., Feb. 07, 2023 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments…